Literature DB >> 24820219

Evaluation of electrolyte repletion in hematopoietic cell transplant patients receiving H-2 receptor antagonists or proton pump inhibitors.

K Smith1, M L Gatesman1, S E Harpe2, W Clark1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24820219     DOI： 10.1038/bmt.2014.88

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  10 in total

1.  Randomized trial of omeprazole or ranitidine versus placebo in the prevention of chemotherapy-induced gastroduodenal injury.

Authors:  S Sartori; L Trevisani; I Nielsen; D Tassinari; I Panzini; V Abbasciano
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

2.  Proton pump inhibitors and risk for recurrent Clostridium difficile infection.

Authors:  Amy Linsky; Kalpana Gupta; Elizabeth V Lawler; Jennifer R Fonda; John A Hermos
Journal:  Arch Intern Med       Date:  2010-05-10

Review 3.  Severe hypomagnesemia during long-term treatment with a proton pump inhibitor.

Authors:  Giuseppe Regolisti; Aderville Cabassi; Elisabetta Parenti; Umberto Maggiore; Enrico Fiaccadori
Journal:  Am J Kidney Dis       Date:  2010-05-20       Impact factor: 8.860

4.  A case series of proton pump inhibitor-induced hypomagnesemia.

Authors:  Ewout J Hoorn; Joost van der Hoek; Rob A de Man; Ernst J Kuipers; Clemens Bolwerk; Robert Zietse
Journal:  Am J Kidney Dis       Date:  2010-02-26       Impact factor: 8.860

Review 5.  Malignancy and renal disease.

Authors:  M Kapoor; G Z Chan
Journal:  Crit Care Clin       Date:  2001-07       Impact factor: 3.598

6.  Hypomagnesemia and proton pump inhibitors: below the tip of the iceberg.

Authors:  Tania Weber Furlanetto; Gustavo Adolpho Moreira Faulhaber
Journal:  Arch Intern Med       Date:  2011-05-09

7.  Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.

Authors:  Robert J F Laheij; Miriam C J M Sturkenboom; Robert-Jan Hassing; Jeanne Dieleman; Bruno H C Stricker; Jan B M J Jansen
Journal:  JAMA       Date:  2004-10-27       Impact factor: 56.272

8.  Proton-pump inhibitor use is associated with low serum magnesium concentrations.

Authors:  John Danziger; Jeffrey H William; Daniel J Scott; Joon Lee; Li-wei Lehman; Roger G Mark; Michael D Howell; Leo A Celi; Kenneth J Mukamal
Journal:  Kidney Int       Date:  2013-01-16       Impact factor: 10.612

9.  Renal complications in oncologic patients.

Authors:  Melissa L Givens; Joy Wethern
Journal:  Emerg Med Clin North Am       Date:  2009-05       Impact factor: 2.264

10.  Incidence and severity of early electrolyte abnormalities following autologous haematopoietic stem cell transplantation.

Authors:  David Philibert; Simon Desmeules; Alain Filion; Mireille Poirier; Mohsen Agharazii
Journal:  Nephrol Dial Transplant       Date:  2007-08-25       Impact factor: 5.992
  10 in total
  1 in total

1.  Does the use of proton pump inhibitors increase the risk of hypomagnesemia: An updated systematic review and meta-analysis.

Authors:  Shengtao Liao; Li Gan; Zhechuan Mei
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.